Home
|

CXR Biosciences is committed to accelerating drug development, reducing late stage product attrition, and accurately determining the safety characteristics of chemicals....
 

CXR Biosciences: your partner in problem solving

At CXR, we combine proprietary technologies and world-class scientific expertise to deliver tailored preclinical services:

By providing expert services and developing innovative technologies, CXR Biosciences can help you:

· ..improve the clinical predictability of drug discovery ADMET screens
· ..reduce late stage product attrition
· ..rescue chemicals and drugs that may otherwise be abandoned
· ..transform human risk assessment of drugs and chemicals



  CXR and Taconic announce launch of transADMET program, ..
TaconicArtemis GmbH has been working with CXR to deliver novel, commercially viable, models that are more predictive of the pharmacokinetic and toxico... »
  CXR Biosciences CSO and Co-Founder Awarded OBE
Professor Roland Wolf, Chief Scientific Officer and Co-Founder of CXR Biosciences Ltd, has been awarded an OBE in the UK New Year’s Honours list in re... »
  Millipore Corporation and CXR Biosciences Introduce Tox..
Millipore Corporation (Billerica, MA) and CXR Biosciences® (Dundee, UK) today launched ToxReporter™, a new panel of engineered cell lines and assays t... »
 

© Copyright CXR Biosciences Scotland 2007 | James Lindsay Place, Dundee Technopole, Dundee, Scotland DD1 5JJ Tel +44 1382 432163
Web Design, Development and hosting by MTC Media